UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease

Metabolism, clinical and experimental, 2016-08, Vol.65 (8), p.1049-1061

2016

Link zum Volltext

Verfügbarkeit prüfen

Nonalcoholic liver disease: Epidemiology, risk factors, natural history, and management strategies

Annals of the New York Academy of Sciences, 2023-08, Vol.1526 (1), p.16-29

2023

Link zum Volltext

Verfügbarkeit prüfen

A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer

Journal of hepatology, 2016-09, Vol.65 (3), p.579-588

2016

Link zum Volltext

Verfügbarkeit prüfen

Current and future pharmacologic treatment of nonalcoholic steatohepatitis

Current opinion in gastroenterology, 2017-05, Vol.33 (3), p.134-141

2017

Link zum Volltext

Verfügbarkeit prüfen

Exercise Does Not Independently Improve Histological Outcomes in Biopsy-Proven Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Genes, 2023-09, Vol.14 (9), p.1811

2023

Link zum Volltext

Verfügbarkeit prüfen

Brivanib attenuates hepatic fibrosis in vivo and stellate cell activation in vitro by inhibition of FGF, VEGF and PDGF signaling

PloS one, 2014-04, Vol.9 (4), p.e92273

2014

Link zum Volltext

Verfügbarkeit prüfen

Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options

Clinical Medicine Insights: Therapeutics, 2016-01, Vol.2016 (8), p.75-84

2016

Link zum Volltext

Verfügbarkeit prüfen

The use of cell free DNA in the diagnosis of HCC

Hepatoma research, 2019, Vol.5 (9), p.21-30

2019

Link zum Volltext

Verfügbarkeit prüfen

Hepatic Hydrothorax: An Independent Predictor of Mortality in Cirrhosis? Is the MELD-Na Score Worth Its Salt?

Digestive diseases and sciences, 2022-10, Vol.67 (10), p.4609-4611

2022

Link zum Volltext

Verfügbarkeit prüfen

Correction: Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling

PloS one, 2015-11, Vol.10 (11), p.e0142355-e0142355

2015

Link zum Volltext

Verfügbarkeit prüfen

Digoxin as an emerging therapy in noncardiac diseases

Trends in pharmacological sciences (Regular ed.), 2023-04, Vol.44 (4), p.199-203

2023

Link zum Volltext

Verfügbarkeit prüfen

Multidisciplinary Management of Hepatic Hydrothorax in 2020: An Evidence‐Based Review and Guidance

Hepatology (Baltimore, Md.), 2020-11, Vol.72 (5), p.1851-1863

2020

Link zum Volltext

Verfügbarkeit prüfen

New uses for an old remedy: Digoxin as a potential treatment for steatohepatitis and other disorders

World journal of gastroenterology : WJG, 2023-03, Vol.29 (12), p.1824-1837

2023

Link zum Volltext

Verfügbarkeit prüfen

Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin‐Like Phospholipase Domain Containing 3–Mediated Acceleration of Steatohepatitis

Hepatology (Baltimore, Md.), 2021-04, Vol.73 (4), p.1290-1306

2021

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Recent advances in the understanding of hepatocellular carcinogenesis

Frontiers in oncology, 2022-07, Vol.12

2022

Link zum Volltext

Verfügbarkeit prüfen

Screening, Diagnosis, and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD): Application of Society Guidelines to Clinical Practice

Current gastroenterology reports, 2023-10, Vol.25 (10), p.213-224

2023

Link zum Volltext

Verfügbarkeit prüfen

Role of candidate gene variants in modulating the risk and severity of alcoholic hepatitis

Alcoholism, clinical and experimental research, 2021-04, Vol.45 (4), p.709-719

2021

Link zum Volltext

Verfügbarkeit prüfen

Treatment of NASH: What Helps Beyond Weight Loss?

The American journal of gastroenterology, 2017-06, Vol.112 (6), p.821-824

2017

Link zum Volltext

Verfügbarkeit prüfen

Enlarging Ectopic Thyroid in the Porta Hepatis: 2434

The American journal of gastroenterology, 2018-10, Vol.113 (Supplement), p.S1356-S1356

2018

Link zum Volltext

Verfügbarkeit prüfen

Derivation and Validation of a Model to Predict Clinically Significant Portal Hypertension Using Transient Elastography and FIB-4

Journal of clinical gastroenterology, 2023-02, Vol.57 (2), p.189

2023

Link zum Volltext

Verfügbarkeit prüfen

Knockout of sulfatase 2 is associated with decreased steatohepatitis and fibrosis in a mouse model of nonalcoholic fatty liver disease

American journal of physiology: Gastrointestinal and liver physiology, 2020-09, Vol.319 (3), p.G333-G344

2020

Link zum Volltext

Verfügbarkeit prüfen

The extracellular sulfatase SULF2 promotes liver tumorigenesis by stimulating assembly of a promoter-looping GLI1-STAT3 transcriptional complex

The Journal of biological chemistry, 2020-02, Vol.295 (9), p.2698-2712

2020

Link zum Volltext

Verfügbarkeit prüfen

Haptoglobin 2 Allele is Associated With Histologic Response to Vitamin E in Subjects With Nonalcoholic Steatohepatitis

Journal of clinical gastroenterology, 2019-11, Vol.53 (10), p.750

2019

Link zum Volltext

Verfügbarkeit prüfen

Updates on Chronic HBV: Current Challenges and Future Goals

Current treatment options in gastroenterology, 2019-06, Vol.17 (2), p.271-291

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(43)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease

Nonalcoholic liver disease: Epidemiology, risk factors, natural history, and management strategies

A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer

Current and future pharmacologic treatment of nonalcoholic steatohepatitis

Exercise Does Not Independently Improve Histological Outcomes in Biopsy-Proven Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Brivanib attenuates hepatic fibrosis in vivo and stellate cell activation in vitro by inhibition of FGF, VEGF and PDGF signaling

Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options

The use of cell free DNA in the diagnosis of HCC

Hepatic Hydrothorax: An Independent Predictor of Mortality in Cirrhosis? Is the MELD-Na Score Worth Its Salt?

Correction: Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling

Digoxin as an emerging therapy in noncardiac diseases

Multidisciplinary Management of Hepatic Hydrothorax in 2020: An Evidence‐Based Review and Guidance

New uses for an old remedy: Digoxin as a potential treatment for steatohepatitis and other disorders

Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin‐Like Phospholipase Domain Containing 3–Mediated Acceleration of Steatohepatitis

Editorial: Recent advances in the understanding of hepatocellular carcinogenesis

Screening, Diagnosis, and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD): Application of Society Guidelines to Clinical Practice

Role of candidate gene variants in modulating the risk and severity of alcoholic hepatitis

Treatment of NASH: What Helps Beyond Weight Loss?

Enlarging Ectopic Thyroid in the Porta Hepatis: 2434

Transcriptional Induction of Periostin by a Sulfatase 2-TGF beta 1-SMAD Signaling Axis Mediates Tumor Angiogenesis in Hepatocellular Carcinoma

Derivation and Validation of a Model to Predict Clinically Significant Portal Hypertension Using Transient Elastography and FIB-4

Knockout of sulfatase 2 is associated with decreased steatohepatitis and fibrosis in a mouse model of nonalcoholic fatty liver disease

The extracellular sulfatase SULF2 promotes liver tumorigenesis by stimulating assembly of a promoter-looping GLI1-STAT3 transcriptional complex

Haptoglobin 2 Allele is Associated With Histologic Response to Vitamin E in Subjects With Nonalcoholic Steatohepatitis

Updates on Chronic HBV: Current Challenges and Future Goals

Suchergebnisse filtern